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Abstract
Progressive cystic kidney degeneration underlies diverse renal diseases, including the most
common cause of kidney failure, autosomal dominant Polycystic Kidney Disease (PKD).
Genetic analyses of patients and animal models have identified several key drivers of this
disease. The precise molecular and cellular changes underlying cystogenesis remain, how-
ever, elusive. Drosophila mutants lacking the translational regulator Bicaudal C (BicC, the
fly ortholog of vertebrate BICC1 implicated in renal cystogenesis) exhibited progressive cys-
tic degeneration of the renal tubules (so called “Malpighian” tubules) and reduced renal func-
tion. The BicC protein was shown to bind to Drosophila (d-) myc mRNA in tubules. Elevation
of d-Myc protein levels was a cause of tubular degeneration in BicC mutants. Activation of
the Target of Rapamycin (TOR) kinase pathway, another common feature of PKD, was
found in BicC mutant flies. Rapamycin administration substantially reduced the cystic phe-
notype in flies. We present new mechanistic insight on BicC function and propose that
Drosophila may serve as a genetically tractable model for dissecting the evolutionarily-con-
served molecular mechanisms of renal cystogenesis.
Author summary
Polycystic kidney disease (PKD) is a degenerative, potentially lethal, genetic malady that
affects 12.5 million people world-wide for which there is no cure. In the kidney, PKD
causes the formation of prominent, fluid-filled cysts the growth of which damages pro-
gressively kidney function. Crucial to PKD development, mutations in the PKD1 and
PKD2 genes cause renal cystic degeneration via factors and mechanisms that are only par-
tially known. This manuscript reports novel insights into the molecular mechanisms of
the evolutionarily conserved RNA binding protein BicC, which has been implicated in
vertebrate cystic kidney diseases. The BicC mutants of the fruit fly Drosophila melanogaster
recapitulate crucial characteristics of PKD. A clear link between BicC and PKD has begun
to emerge, in part because both PKD1 patients and Pkd1 mice exhibit reduced BicC func-
tion. This first in kind Drosophila model of renal cystogenesis offers strong potential to
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decipher the complex mechanisms of the molecular and cellular changes causing renal
cyst formation.
Introduction
Maintenance of structural and functional integrity of the kidney is a complex, crucial task pre-
sided over by the activity of numerous genes. Renal cyst formation can result from the muta-
tion of at least one of over 57 genes [1,2]. Multiple, clinically relevant, forms of cystic kidney
disease exist, exhibiting different modalities of genetic inheritance: syndromic, non-syndro-
mic, dominant, and recessive [2]. Autosomal Dominant Polycystic Kidney Disease (ADPKD)
is the most common cause of end-stage renal failure, affects 12.5 million people world-wide
and has an incidence of 1–2 cases per 2000 live births world-wide [1]. Mutations in the PKD1
and PKD2 genes account for the majority of the genetic lesions in ADPKD patients [3,4].
ADPKD causes the loss of polarity in the cells of the renal tubule epithelium and the develop-
ment of fluid-filled cysts and interstitial fibrosis in the kidney [1,5,6,7]. Several animal models
have been studied to identify the pathways and the complex changes that eventually lead to
renal cystogenesis [8]. Among these, activation of the mammalian (m) TOR pathway was
found in various forms of renal cystic pathologies, including human ADPKD cysts, autosomal
recessive PKD, and rodent models of PKD and nephronophthisis [5,6,7,9,10,11]. TOR is a con-
served serine threonine kinase central to controlling cellular anabolic processes via protein
translation, ribosome biogenesis, nutrient sensing/transport and mitochondrial metabolism
[12,13,14]. TOR is often dys-regulated in disease [12,15]. The stages and pathological progres-
sion of PKD cystogenesis are known [1]. Although genetic analyses have indicated that some
signaling pathways are altered in PKD tissue, the precise molecular and cellular changes
underlying cystogenesis in PKD and other diseases remain elusive.
Mutations in the Bicaudal C (BicC) gene in many vertebrates are associated with the devel-
opment of renal cysts [16,17,18,19]. BicC proteins are a family of RNA binding factors of
which the prototypical member, BicC, was demonstrated to be necessary for establishing the
correct anterior-posterior polarity of the embryo of the fruit fly Drosophila melanogaster
[20,21]. Subsequent studies reported that BicC functions to establish polarity of the oocyte,
and consequently of the embryo. During oogenesis BicC recruits the CCR4-NOT deadenylase
to its target mRNAs and regulates cytoplasmic polyadenylation, eventually affecting transla-
tion [22,23,24].
Evolutionarily conserved from Drosophila to vertebrates, BicC is abbreviated as Bicc1 and
BICC1 for mouse and humans respectively [20]. Several lines of evidence have implicated
Bicc1 and BICC1 in renal function and cystogenesis. Mutations in Bicc1 as well as in its Xeno-
pus and zebrafish orthologs result in cystic kidneys [16,19,25,26]. In humans, two BICC1muta-
tions were identified in patients with cystic kidney dysplasia [17]. Bicc1 can associate with the
Ank and NPHP proteins in a complex important for the development of the zebrafish pro-
nephros [27]. The Bicc1/Ank/NPHP complex was implicated in human nephronophtisis, a
cystic kidney disease characterized by multiple extra-renal manifestations [28]. Moreover, a
30% reduction in Pkd2 mRNA levels has been observed in Bicc1 mutant mice [25]. Despite the
numerous vertebrate BicC animal models, the precise molecular mechanisms underlying
BicC-dependent kidney degeneration are largely unknown.
The Drosophila renal function is carried out by two pairs of renal tubules, specifically called
Malpighian tubules [29], and anatomically separated nephrocytes, that resemble vertebrate
podocytes [30]. The fly Malpighian tubules are regarded as morphologically and functionally
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equivalent to the vertebrate renal tubule. Fly and vertebrate tubules both are composed of a
tubular epithelium, contain distinct physiological regions, produce primary urine and reab-
sorb some solutes [31,32]. The transcriptomes of the Malpighian tubule and the human renal
tubule are also remarkably similar [33]. Several fly models exist for various kidney diseases
[34] because of the evolutionary conservation of renal function; however, no Drosophila mod-
els have been described for cystic kidney disease.
Herein, we report that Drosophila BicC mutants developed cysts in the Malpighian tubules
and provide novel evidence of the mechanism of BicC regulation. BicC was found to bind
directly the d-myc mRNA. Characteristic of cystic tubule degeneration and PKD, BicC mutants
exhibited both d-myc up-regulation and TOR pathway activation. Moreover, underscoring
conserved causative mechanisms, rapamycin, a TOR inhibiting drug known to ameliorate
PKD defects in vertebrates, was shown to be effective in reducing the defects observed in BicC
mutant flies. Notably, BicC was significantly down-regulated in PKD tissue, both in patients
and in mouse Pkd1 models, indicating that BicC is genetically downstream of PKD1. Therefore,
Drosophila BicC mutants appear to provide a valid model to dissect the molecular and cellular
aspects of cyst biology.
Results
Impaired BicC function induces renal cystogenesis in Drosophila
As seen by light microscopy, wild-typeMalpighian tubules were thin and elongated, with regular
diameter. This appearance was constant over thirty days of adult life (Fig 1A–1C). In contrast,
BicC mutant tubules from Df(2L)RA5/BicCYC33 and Df(2L)RA5/BicCIIF34 flies (subsequently
referred to as BicCΔ/YC33 and BicCΔ/IIF34 respectively) exhibited deformations from early age (1
day, Fig 1D–1F and 1G–1I, respectively). Disorganization of the tubular epithelial cells and
irregularly distributed enlargements were consistently observed in the BicC mutant flies.
The Malpighian tubule malformations were reminiscent of the defects observed in various
forms of human PKD [35]. At an early age the tubules appeared severely affected and pre-
sented large, often numerous cysts in both BicCΔ/YC33 and BicCΔ/IIF34 flies (Fig 1D, 1G and 1J).
When the BicC mutant flies approached 14 days of age, both tubules displayed irregularities,
appeared enlarged, and presented numerous deformities (Fig 1E, 1H and 1K). Prominent
enlargements closely resembling cysts appeared filled with fluid and floating dark crystalline
particles that were not observed in the wild-type controls that were raised in parallel under
identical conditions. Dense, amorphous, material could also be seen in long sections of the
BicC tubules and -rarely- in short sections of the wild-type tubules from old flies. Unlike wild
type, that maintained thin, elongated Malpighian tubules, at 30 days, BicC flies displayed mul-
tiple cysts in both tubules and prominent deformities of the anterior terminal tubule (Fig 1C,
1F, 1I and 1L). Additionally, extra tubular budding and branching were observed exclusively
in BicC mutant tubules (Fig 1J and 1L). To better characterize the defects and the progression
of the phenotype over time, we scored the incidence of cystic deformations in Malpighian
tubules dissected from 50 flies (100 anterior and 100 posterior tubules) of each genotype and at
different ages. Both pairs of Malpighian tubules displayed cysts, especially in the terminal and
intermediate regions (observed in 42–100% of cases, Fig 2A–2C), which was reminiscent of
PKD that is reported to affect preferentially the terminal section of the nephron [36,37]. Akin
to PKD [36] the BicC tubules also presented extra branching (9–46% of cases). The cysts of the
BicC Malpighian tubules appeared to become more numerous over time, albeit the deaths of
many flies influenced the representation of the different classes (Fig 2D).
Considering that the BicC mutation causes renal cystogenesis in vertebrates [16,17,19,
25,26], immunostaining was performed using species-specific antibodies to characterize
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expression and distribution of the BicC protein in wild-type Malpighian tubules and of its
ortholog Bicc1 in kidney sections from C57BL/6 wild-type adult mice. Drosophila BicC was
expressed in the Malpighian tubule epithelium (Fig 3A–3D). Similarly, mouse Bicc1 was found
at highest levels in the renal tubule epithelium, with a much lower signal in the medullar region
(Fig 3E–3H). Thus, consistent with the homologous primary structure [20], the Drosophila
and the mouse BicC proteins are both expressed in the renal tubules, suggesting a possible
functional conservation.
BicC is necessary for proper Malpighian tubule function in Drosophila
Cyst formation and interstitial fibrosis cause chronic kidney disease and kidney failure by age
55 in 50% of all PKD patients [8]. To investigate if the morphological defects in BicC mutant
Malpighian tubules had phenotypic consequences, we assessed the viability of wild-type and
mutant adult flies. Compared to wild-type, both BicCΔ/YC33 and BicCΔ/IIF34 mutant flies dis-
played impaired survival, with population decrease by day 9 to 91.5 ± 1.9% and 57 ± 6.6% sur-
vival for BicCΔ/YC33 and BicCΔ/IIF34 respectively, contrasted to 99.5 ± 1% survival for wild-type
(n = 200; Fig 4A). Populations of BicCΔ/YC33 and BicCΔ/IIF34 mutants reached 50% survival at 28
and 16 days respectively, compared to 48 days for wild-type flies. Notably, BicCΔ/+ heterozy-
gotes displayed similar survival to wild-type (S1 Fig) and were not further analyzed. Impaired
viability correlated with renal degeneration. Malpighian tubules dissected from moribund flies
were misshapen, displayed large fragile cysts, and often contained prominent impacted mate-
rial (Fig 4B).
Fig 1. BicC is necessary for proper renal tubule function. Malpighian (fly renal) tubules were dissected and photographed (light
microscopy) at 1 day (A, D, G) or 14 days (B, E, H) or 30 days (C, F, I). Compared to OreR wild-type flies (wt, A-C), the BicCΔ/YC33
(D-F) and the BicCΔ/IIF34 (G-I) mutant flies both displayed cystic tubules. Both Malpighian tubules degenerated over time, with cysts
evident throughout the whole tubule and in both tubules by day 14 (compare A, D, G with B, E, H and C, F, I). Enlargements of the
boxed areas in (G, H, I) are shown respectively in (J, K, L), highlighting the tubular deformities. The normal single-cell layer of the
renal tubule epithelium appeared disorganized in the mutant flies, which had abnormal tubule budding and branching (arrows).
Malpighian tubules dissected ex vivo from BicC mutants contained various crystalline particles apparently floating in the luminal fluid
(arrowheads) that were not observed in wild-type flies raised in parallel under identical conditions. Scale bar: 1 mm (A-I) or 312.5 μm
(J, K, L).
https://doi.org/10.1371/journal.pgen.1006694.g001
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Malpighian tubule function was tested by placing flies in a cornmeal medium containing
0.5M NaCl. The hypertonic medium acts as a stress that may be used to reveal diminished Mal-
pighian tubule function. Under the high-salt conditions survival of the wild-type was greatly
impaired, with populations reaching 50% in ~2.2 days and 0% at 4–5 days. Compared to wild-
type, BicCΔ/YC33 and BicCΔ/IIF34 fly lifespans were shortened, with populations steadily declin-
ing from exposure to high salt medium and reaching 50% survival at 1.8 and 1 days respec-
tively (Fig 4C, n = 150). Differential survival did not appear to be due to starvation, because all
genotypes appeared to feed normally on high salt food stained with food dye (S2 Fig). Taken
together, our observations indicate that BicC is required for proper renal tubule function in
Drosophila.
Fig 2. Quantification of the Malpighian tubule cystic phenotype of BicC flies. Malpighian tubules from wild
type, BicCΔ/YC33 and BicCΔ/IIF34 (50 flies each) were dissected at age one day (A), 10 days (B), and 30 days (C) and
scored phenotypically ex vivo. Shown are the percentages of tubules affected in the terminal, intermediate, and
proximal regions, as well as the observed extra tubular branching. Anterior and posterior tubules were scored
separately. Tubular cyst number from the same sample is shown (D). The occurrence of BicCΔ/YC33 tubules
displaying at least four cysts appeared to increase over time. The same class in the BicCΔ/IIF34 tubules was more
numerous at one day of age, was less represented at ten days, and increased again in the older flies (Fig 2D),
possibly reflecting mortality of the more severely affected flies (see text).
https://doi.org/10.1371/journal.pgen.1006694.g002
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Fig 3. BicC expression in renal tissue. Confocal section of Drosophila Malpighian tubules with BicC
immunofluorescent staining (red, A, C, D) and DAPI nuclear staining (blue B, C) show that BicC is expressed
in the principal cells. Boxed area in (A) is shown enlarged in (D). Epifluorescence microscopy of a 5 μm kidney
section from C57BL/6 mice shows Bicc1 accumulation in the cells lining the renal tubule (red, E, G, H). DNA,
DAPI (blue, F, G). Panel (H) is an enlargement of the boxed area in (E). Scale bars: 20 μm.
https://doi.org/10.1371/journal.pgen.1006694.g003
Fig 4. BicC flies exhibit severe renal defects and impaired survival. (A) Survival curves of fly populations (n = 200, standard deviations are shown) of
wild-type (wt), BicCΔ/YC33 (Δ/YC33) and BicCΔ/IIF34 (Δ/IIF34). Compared to wild-type, both BicCΔ/YC33 and BicCΔ/IIF34 flies have impaired survival, reaching
50% respectively at 48, 28, and 16 days after adult eclosion. (B) Malpighian tubules dissected from a moribund BicCΔ/IIF34 fly showed severe deformities with
large cysts containing apparent impacted materials; scale bar: 100 μm. (C) BicCΔ/YC33 and BicCΔ/IIF34 flies exhibited sensitivity to salt stress. Fly populations
(wild-type, BicCΔ/YC33, BicCΔ/IIF34, n = 150, standard deviations are shown) placed in vials containing cornmeal agar with 0.5M NaCl were at a disadvantage
and had shorter life span than the wild-type controls.
https://doi.org/10.1371/journal.pgen.1006694.g004
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BicC downregulates d-myc in the Malpighian tubule
In the Drosophila ovary BicC is a negative regulator of translation and functions by first binding
to its mRNA targets [20,24]. To examine BicC role(s) in the Malpighian tubule, RNA-protein
(RNP) complexes were immunoprecipitated from extracts of Malpighian tubules from wild-
type flies with either the BicC antiserum or a non-immune serum. The content of d-myc RNA
was specifically analyzed in the BicC-associated RNA pool, because of the important role c-Myc
plays in kidney cystogenesis in mammals [38,39,40,41]. Unlike the non-immune control, an
RT-PCR product for the d-myc mRNA was specifically obtained from BicC RNP immunopre-
cipitates (Fig 5A). In the ovary, BicC binds its own mRNA, downregulating its expression [24].
Using BicC-specific primers, we obtained an RT-PCR product from the BicC immunoprecipi-
tates, suggesting that BicC could also bind its own mRNA in the Malpighian tubule, likely by an
auto-regulatory loop as observed in the ovary. Conversely, tubulin84B-specific primers did not
yield any RT-PCR products from either anti-BicC or control immunoprecipitates, indicating
Fig 5. BicC regulates d-myc expression in the Malpighian tubule. (A) RT-PCR of RNA immunoprecipitated with either non-immune control
serum (NI, lane 1) or BicC antiserum (αBicC, lane 2). A product specific for d-myc was amplified exclusively from the BicC immunoprecipitate,
indicating that BicC regulates d-myc mRNA in the Malpighian tubule. Similar to the situation in the ovary [24], BicC primers used as positive control
also yielded a specific product only in the immunoprecipitate. In contrast, tubulin 84B primers did not produce any amplification product, showing
that the immunoprecipitation was specific (negative control). Lane 3: PCR negative control (-, no cDNA). Lane 4: PCR positive control (+, cDNA,
Malpighian tubule total cDNA). (B) RT-PCR of control RNA immunoprecipitation from wild type and Df(2L)RA5/Df(2L)Osp29 (BicC null, ΔBicC)
Malpighian tubules. For both extracts RNP particles (RNPs) were captured with either non-immune control serum (NI, lane 1, 3) or BicC antiserum
(αBicC, lane 2, 4). d-myc-specific amplification products were exclusively observed for wild type extracts with the RNP captured by the BicC
antiserum, but not with those captured by the non-immune serum. Neither non-immune nor BicC antiserum recovered d-myc containing particles.
RNAs extracted from small aliquots of the input extracts (respectively ΔBicC and wild-type) also produced distinct clear PCR products. (C)
Representative immunoblots of extracts of Malpighian tubule (four pairs per lane) from wild-type (wt), BicCΔ/YC33 and BicCΔ/IIF34 flies probed for d-
Myc and tubulin (left). Corresponding graphs of means ± standard deviations of d-Myc levels relative to tubulin (right). Values were calculated from
independent biological replicas (n, indicated) and p values (Student’s t test) are shown (right). Myc/tubulin ratios were normalized to the wild-type
average. d-Myc protein levels were generally higher in BicC mutants and increased with age.
https://doi.org/10.1371/journal.pgen.1006694.g005
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that the experimental conditions were selective for RNP complexes specifically containing BicC.
Importantly, all primers amplified the expected size products when the reaction was spiked with
cDNA synthesized from total RNA extracted from wild-type Malpighian tubules. To confirm
the selective enrichment of the d-myc mRNA we repeated the RNP immunoprecipitation with
immune and non-immune sera using extracts from flies either wild type or containing two over-
lapping deletions that remove the BicC gene, Df(2L)RA5and Df(2L)Osp29 (ΔBicC). While a d-
myc-specific PCR product was obtained from the wild type RNA associated with the BicC antise-
rum, no such product was observed for the RNPs recovered from the BicC deleted extract (Fig
5B). The immunoprecipitation with the non-immune serum yielded no amplification product
from both extracts, suggesting that the BicC protein and the d-myc RNA may interact in vivo.
In the ovary, BicC regulates negatively the expression of its own targets. Therefore, the levels
of d-Myc protein in wild-type and BicC Malpighian tubules were compared relative to tubulin.
Quantitative immunoblots of extracts from four pairs of Malpighian tubules which were dissected
from flies of different ages (0, 6, 30 days old), revealed that tubules from BicCΔ/YC33 mutants con-
tained from two to seven times more full-length d-Myc protein than wild-type tubules from flies
of identical age that were raised in parallel (Fig 5C, p = 0.0074, 0.0100, 0.0204 respectively). d-
Myc levels in BicCΔ/IIF34 tubules were also significantly above those of wild-type in the 6 and 30
days old samples (Fig 5C, p = 0.0021 and 0.0078 respectively).
c-Myc is upregulated in PKD kidneys [38,39,40,41,42,43] and its overexpression can induce
renal cystogenesis in mice [39,40]. To characterize the consequences of d-Myc over-expression
in the Malpighian tubules and to pinpoint how elevated d-Myc may contribute to the BicC cys-
tic renal phenotypes, we overexpressed d-Myc both in principal and stellate cells (the main cell
types of wild-type Malpighian tubules) of wild-type animals using the {UAS-d-Myc}32 [44]
transgene and cell-specific Gal4 drivers c42 and c724 [45] to drive expression in principal and
stellate cells respectively. Very few individuals over-expressing d-myc survived to adulthood.
These rare escapers exhibited severely deformed Malpighian tubules, which were swollen and
disorganized (compare Fig 6A–6C with D-F and G-I). Compared to BicCΔ/YC33, Malpighian
tubules over-expressing d-Myc were severely deformed and, unlike the tubules of BicC mutant
flies, did not appear to have extra tubular branching. d-Myc immunostaining (Fig 6A, 6D and
6G) and immunoblots of Malpighian tubule extracts from these flies (Fig 6J and 6K) confirmed
that d-Myc was indeed substantially overexpressed relative to controls (3–34 X, p = 0.0440).
Consistent with the observed severity of the d-myc over-expression defects, Myc levels in the
Malpighian tubules of such flies were up to an order of magnitude higher relative to the BicC
mutants.
To verify if the Malpighian tubule cysts of the BicC flies were due at least in part to the
observed up-regulation of d-Myc, we tested if cystogenesis could be suppressed by expression
of a dsRNA transgene, TRiP.JF01762, [46,47] that targeted d-myc in both principal and stellate
cells. The resulting flies (denoted as BicCYC33; mycRNAi) were dissected and Malpighian tubules
from the various genotypes were examined by light microscopy to assess tubular morphology.
Compared to the sibling BicCYC33/YC33 flies that displayed prominent cysts (Fig 7A–7C), Bic-
CYC33/YC33; mycRNAi flies exhibited substantial morphological rescue (Fig 7D and 7E).
Consistent with the results shown in Fig 5C, immunoblots of Malpighian tubule extracts
from these genotypes revealed that, relative to tubulin, d-Myc levels in the BicCYC33/YC33
tubules were increased over two-fold compared to the wild-type (p = 0.0264). Compared to
wild-type, d-myc RNAi slightly reduced d-Myc levels when induced in a wild-type back-
ground. In contrast, RNA interference in the BicCYC33/YC33; mycRNAi flies reduced d-Myc to the
levels of the wild-type and transgene heterozygote controls (Fig 7F and 7G). Myc RNAi in the
BicCYC33/YC33 tubules reduced the incidence of cysts in the terminal and in the proximal tubule
and could decrease swollen tubular sections, compared to Malpighian tubules from sibling
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BicCYC33/YC33 flies (Fig 7H). These results were confirmed with an independent line, TRiP.
JF01761, which reduced Myc expression less efficiently than TRiP.JF01762 (S3 Fig). Staining
with DAPI indicated that, in contrast to BicCYC33/YC33 tubules, which appeared enlarged with
irregular distribution of principal cell nuclei, in the thinner-looking tubules from BicCYC33/YC33;
mycRNAi flies, cell nuclei appeared more regularly distributed and evenly shaped (Fig 7, compare
I with J and K). We conclude that d-Myc up-regulation contributes substantially to the BicC cys-
tic tubule phenotype.
TOR pathway upregulation contributes to the cystic phenotype in BicC
mutant flies
The activation of the mTOR pathway underlies many forms of renal cystogenesis, including
both autosomal dominant and recessive PKD [6,7,48,49]. Since the observation that cystic pro-
gression was reduced in ADPKD patients undergoing post-transplantation immune suppres-
sant therapy with rapamycin [7], the rapamycin derivatives Everolimus and Sirolimus have
been examined in clinic and animal models to ameliorate kidney conditions and to delay cystic
growth in the short term [50,51,52,53,54]. In light of the observed cystic defects in the BicC
Fig 6. d-Myc overexpression in the Malpighian tubule causes severe cellular and tubular defects. Confocal sections of d-Myc immuno-
staining of Malpighian tubules from wild-type flies (A-C), BicCΔ/YC33 flies (D-F), and flies with d-Myc Gal4-driven over-expression in both principal
and stellate cells (Gal4>d-myc, G-I). d-Myc (red), DNA (DAPI, blue). d-Myc over-expression in the Malpighian tubules caused severe defects. The
irregular shape and density of nuclei are suggestive of tissue disorganization. All images in this panel were captured with identical settings and the
signal for d-Myc staining in the Gal4>d- myc tubule (G) was saturated, indicating higher levels of d-Myc over-expression relative to those induced by
BicC mutation. Scale bar: 50 μm. (J) Representative immunoblot of extracts of Malpighian tubules dissected from wild-type (wt) flies, flies hetero-
zygote for the Gal4-d-myc construct (Gal4/+) and flies over-expressing d-myc c724/+; c42/Gal4>d-myc (Gal4>d-myc) probed for d-Myc and α-
tubulin. (k) Graph of means ± standard deviations of d-Myc levels relative to tubulin from five independent biological replicas per each genotype.
Values were normalized to the wild-type average; p values (Student’s t test) are shown. d-myc (d-Myc/tubulin) over-expression in Malpighian
tubules ranged from three to over 30 times the levels in tubules of control flies.
https://doi.org/10.1371/journal.pgen.1006694.g006
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Fig 7. d-myc knockdown can rescue the Malpighian tubule defects of BicC mutants. Light microscopy of dissected Malpighian tubules
from sibling BicCYC33/YC333 (A, B, C, control) and BicCYC33/YC33; mycRNAi (D, E) flies in which RNAi was induced in both principal and stellate
Renal cystogenesis in the BicC fly
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mutant flies, we tested if administration of rapamycin to adult flies could modify such cystic
phenotype. The BicCΔ/IIF34 flies that were administered solvent alone (vehicle) exhibited the
expected decreased fitness and rapid population decline relative to wild-type controls (50%
survival at ~11 days; Fig 8A).
In contrast, BicCΔ /IIF34 mutants that were treated with 15 μM rapamycin exhibited substan-
tial rescue, with no death observed before 10 days and 50% survival extended nearly two-fold
to ~22 days (compare Fig 8A and 8B). Populations of BicC flies that were administered rapa-
mycin eventually declined (Fig 8B), reminiscent of the short-term effectiveness of rapamycin
treatment in rodent models of renal cystic disease [54]. Consistent with the observed rescue,
the Malpighian tubules that were dissected from rapamycin-treated BicCΔ/IIF34 flies showed
substantial improvements compared to those from vehicle-treated BicCΔ/IIF34 flies of the same
age with rare, minimal-sized cysts and no extra branching, even at older ages (Fig 8C and 8D).
Similar to observations of both Drosophila [55] and other treated organisms [56,57,58], rapa-
mycin administration extended wild-type longevity.
Phosphorylation of the mTOR downstream target p70 ribosomal S6 kinase has been
observed in both ADPKD human tissue and in mouse PKD models [7]. Comparative analysis
of the Drosophila p70-S6 kinase [59] (hereby d-S6K) in the tubules from rapamycin or vehicle
treated flies revealed that BicCΔ/IIF34 mutant tubules contained twice as much phosphorylated
d-S6K relative to total d-S6K than wild-type (Fig 8E). In contrast, rapamycin-treated sibling
flies, processed in identical conditions and in parallel, exhibited a similar ratio of phosphory-
lated vs. un-phosphorylated d-S6K (Fig 8E).
An evolutionarily-conserved functional link between BicC, renal
cystogenesis, and PKD
Two BicC point mutations were identified in patients with cystic kidneys [17]. To test if BicC
was altered in the context of the molecular defects underlying PKD, we analyzed publicly avail-
able microarrays from PKD1 ADPKD patients [60] and found that BicC was significantly
downregulated in cystic relative to healthy renal tissue (p = 0.0196). This suggested that BICC1
may be genetically downstream of PKD1 in kidneys. Consistent with this possibility, we
observed a severe decrease in Bicc1 protein levels in kidneys of Pkd1-/- newborn mice com-
pared to their Pkd1+/+ siblings (Fig 9, similar to reports of whole embryos in [61]).
Discussion
In this work, we show that BicC mutation in Drosophila induced cellular and molecular defects
typical of renal cystogenesis and PKD and that both human ADPKD tissue and Pkd1-/- mice
cells with the c42 and c724 drivers respectively. d-myc RNAi rescued greatly the morphology of the Malpighian tubule. Boxed regions in (A)
and (D) are shown enlarged respectively in (B, C) and (E). (F) Representative d-Myc and tubulin immunoblots of extracts from five Malpighian
tubules dissected from flies of the following genotypes: wild-type (wt); heterozygotes for the Gal4 driver c724 and c42 constructs (Gal4/+);
heterozygotes for the d-mycRNAi construct (mycRNAi/+); myc RNAi driven by c724 and c42 (Gal4>mycRNAi); BicCYC33/YC33 homozygotes
(BicCYC33); myc RNAi driven in BicCYC33 homozygotes (BicCYC33; Gal4>mycRNAi). The latter two genotypes were sibling flies from the same
crosses. (G) Corresponding graph summarizing quantitative immunoblots of means ± standard deviations of d-Myc/tubulin ratios from three
independent biological replicas per each genotype. Values were normalized to the wild-type average. The p value (Student’s t test) is shown
for the BicC mutants. Reducing d-myc expression in BicCYC33/YC33 mutants restored the d-Myc protein to control levels. (H) Cystic scoring of
the BicCYC33/YC33; Gal4/+ (red, n = 100) and BicCYC33/YC33; Gal4/mycRNAi (blue) sibling flies. Results are shown for the lines TRiP.JF01762
(dark blue, n = 100) shown above, and TRiP.JF01761 (light blue, n = 80, see supplemental information). RNAi-induced d-Myc reduction
decreased cystic deformities in the terminal and intermediate tubules. Results for the anterior and posterior tubules are shown separately.
(I-K) Confocal sections of Malpighian tubules dissected from BicCYC33/YC33 flies (I, control) and BicCYC33/YC33; mycRNAi flies (J, K) stained
with DAPI. The distribution of cell nuclei in BicC Malpighian tubules (I) appeared disturbed (compared with wild-type in Figs 3B and 6B) with
disrupted cell arrangement and cystic enlargements. Defects were largely rescued by reducing d-myc expression via RNAi specifically in the
principal and stellate cells of the Malpighian tubules (J, K). Scale bar: 100 μm.
https://doi.org/10.1371/journal.pgen.1006694.g007
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are characterized by decreased BicC function, which is likely to contribute to their characteris-
tic cystic degeneration. BicC mutation in Drosophila caused progressive cystic degeneration of
Fig 8. TOR upregulation and rapamycin rescue of BicC mutant flies. (A) Control wild-type (wt) and BicCΔ/IIF34 (Δ/
IIF34) flies that were administered equal volumes of solvent (ethanol, vehicle) showed the characteristic impaired
survival of BicC mutants compared to wild-type. (B) In contrast, sibling flies of both genotypes that were administered
rapamycin exhibited markedly improved survival of the BicC mutants compared to control flies that were administered
vehicle. A, B n = 200, standard deviations are shown. Rapamycin administration did not compromise survival of the
wild-type flies. Rapamycin appeared to induce almost complete rescue at early time points and substantial rescue
over time. Malpighian tubules of vehicle (C) and rapamycin-treated (D) BicCΔ/IIF34 flies showed marked morphological
rescue with fewer cysts and more regular tubule structure. (E) Total and phosphorylated S6K immunoblots of extracts
from wild type and BicCΔIIF34 Malpighian tubules from flies administered rapamycin or vehicle for 8 days post-eclosion
indicated apparent mitigation of the TOR up-regulation in the BicC mutants.
https://doi.org/10.1371/journal.pgen.1006694.g008
Fig 9. Bicc1 downregulation in Pkd1-/- mice. (A) In accordance to our analyses of human microarrays of
PKD patients, Bicc1 immunoblots of kidney extracts from newborn littermates Pkd+/+ and Pkd1-/- showed that
all Pkd1-/- renal tissues exhibited considerable Bicc1 downregulation. GAPDH: loading control.
https://doi.org/10.1371/journal.pgen.1006694.g009
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the renal tubule with remarkable similarity to the defects typical of human PKD. BicC mutant
flies exhibited enlarged Malpighian tubules and fluid-filled cysts from the time of their hatch-
ing. Cyst number, size and severity increased over time. Moreover, the terminal and collector
tubules appeared to be particularly affected, with frequent extra branching. Compared to wild-
type flies, BicC mutants displayed reduced longevity and greater sensitivity to salt stress. Malpi-
ghian tubules dissected from moribund BicC flies were severely degenerated, indicative of
compromised renal function.
We found that the BicC protein was similarly expressed in the cells of the renal tubular epi-
thelium in both Drosophila and mice. BicC is an RNA binding protein that downregulates
post-transcriptional expression of its target mRNAs in Drosophila [20,24]. Evidence for a link
between BicC and renal cysts was obtained by immunopurification of BicC RNP particles
from wild-type flies, which were found to contain specifically enriched d-myc mRNA, with up-
regulation of Myc being a hallmark of cystic proliferation. Consistent with the profile of cysts,
d-Myc protein was elevated in the Malpighian tubules of BicC flies. Moreover, d-Myc over-
expression in the Malpighian tubules produced very deformed cystic tubules in rare survivors.
The effects of d-Myc over-expression were more severe than BicC defects, likely attributable to
the much higher d-Myc levels in the former (3-34X) than the latter (2-7X). Consistent with the
possibility that the d-myc up-regulation in BicC mutants greatly contributes to the cystic phe-
notype, d-myc depletion via RNAi restored wild-type d-Myc protein levels in BicC tubules and
substantially–albeit not completely–improved morphology. Therefore, de-regulation of other,
still unknown, BicC targets is likely to contribute to the cystic degeneration of the renal tubule.
As in human and mice PKD tissue, Drosophila Malpighian tubules from BicC flies displayed
elevated d-S6K phosphorylation, compared to wild-type, indicating TOR pathway activation.
Of note, d-S6K phosphorylation may amplify the effects of d-myc over-expression [63]. The
ratio between phosphorylated and un-phosphorylated d-S6K of BicC tubules was found to be
twice as high as the wild-type, but rapamycin treatment restored wild-type levels. Consistently,
rapamycin administration to the BicC flies markedly improved survival and reduced cystogen-
esis, albeit fly populations declined over the long term, as reported previously for PKD patients
and rodent cystic models, indicating that repression of the TOR pathway rescued the cystic
defects of the BicC Malpighian tubules. Rapamycin treatment was well-tolerated by wild-type
flies, which displayed increased longevity. In vertebrate cystic models of PKD, long-term treat-
ment with rapamycin has proven challenging because of habituation and possible toxicity
[54,62]. Application of the BicC flies to elucidate the molecular mechanisms of cyst formation
may thus empower the design of more effective therapeutic strategies.
Taken together, our findings are congruent with studies of vertebrate BicC: BicC function is
needed for kidney homeostasis in vertebrates, mutations cause renal cysts in zebrafish, Xeno-
pus and mice [16,19,26], and two BicC mutations were found in patients with infantile, unilat-
eral renal cystic dysplasia [17]. Zebrafish BicC was also recently found in a protein complex
with NPHP proteins [27] that are implicated in nephronophthisis [28]. This evidence suggests
that evolutionarily conserved BicC functions are crucial for the physiology of the renal tubule
and highlight the need for further study of the mechanism(s) and targets of BicC in the kidney
and specifically in the renal tubule. Because decreased BicC expression was a feature of both
microarrays from human PKD1 tissue and Pkd1-/- mouse kidney extracts, a strong nexus
between the BicC and PKD phenotypes is beginning to emerge. BicC-mediated cellular func-
tions such as post-transcriptional regulation of mRNAs may be part of evolutionarily-con-
served pathways that are critical for kidney homeostasis, the malfunction of which leads to
renal cystogenesis and PKD. The Drosophila Malpighian tubule promises to be a useful and
genetically tractable system for further exploring the cellular and molecular changes that con-
tribute to cystic kidney diseases and PKD.
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Methods
Fly lines and survival assays
Flies were grown on cornmeal agar (Jazzmix) at room temperature (~23 degrees) and aged as
indicated. For salt stress the cornmeal food was supplemented with crystalline NaCl to reach a
final concentration of 0.5M NaCl. Food coloring was added to test feeding. Rapamycin (LC
Laboratories) was dissolved in absolute ethanol and added to the fly food (final 15μM rapamy-
cin, 1.5% ethanol). Unlike OregonR wild-type flies that were maintained by standard methods,
BicC flies were generated by crossing CyO balanced stocks containing Df(2L)RA5 (Blooming-
ton Stock Center) and BicCYC33 or BicCIIF34 mutations[22] respectively and retrieving non-Cy
progeny. The BicCYC33 and BicCIIF34 mutations gave rise to truncated proteins in the ovary, of
which the former was present in low amounts (S4 Fig) and initially missed (see Fig 1 in [22]).
The BicCIIF34 allele gave rise to the most severe phenotypes in both the Malpighian tubules and
the ovary, suggesting it may behave as dominant negative. Because Df(2L)RA5double balanced
flies are semi-lethal, the RNA interference transgenes and Gal4 drivers were crossed into Bic-
CYC33 homozygotes. Note the BicCYC33 homozygotes were previously used in [24] to study
ovarian development. BicC null flies were obtained by crossing Df(2L)RA5 and Df(2L)Osp29
(Bloomington Stock Center). Survival assays: for each genotype four cornmeal agar vials with
50 females and 12 males were set up. Flies were passed in fresh vials every three (normal and
rapamycin-containing food) or one (high salt food) days and survivors counted. Percentage sur-
vival rates with standard deviations were plotted against time (Excel). For the rapamycin rescue,
one day old flies (raised in Jazzmix) were placed in vials containing rapamycin or the same vol-
ume of solvent (ethanol, 1.5% final, vehicle control) and moved to fresh vials every three days.
d-myc RNAi: the Gal4 drivers for the principal and stellate cells, c42 and c724 [45] and Gal4-in-
ducible RNAi constructs targeting d-myc,: y1 v1; p{y+t7.7 v+t1.8 = TRiP.JF01761}attP2 and y1 v1;
p{y+t7.7 v+t1.8 = TRiP.JF01762}attP2 (Bloomington Drosophila Stock Center) were introduced
into the BicC background by crossing. To minimize possible environmental effects on gene
expression, all the fly genotypes used in each assay were raised and processed simultaneously in
parallel. d-myc overexpression: the UAS Gal4 transgene w1118; P{w+mC = UAS-Myc.Z}132 [44]
(Bloomington Drosophila Stock Center) was induced via the c724 and c42 drivers at 18˚C.
Immunoblots
Malpighian tubules were micro-dissected in PBS. Four tubule pairs per each lane were lysed
in RIPA, 1x Complete (Roche), 2X Laemmli sample buffer at 100˚C, resolved on 10% SDS
Laemmli polyacrylamide gels (PAGE) and transferred to PVDF.
Mice from Pkd1 were backcrossed on C57BL/6J background for several generations and
genotyped as in [64]. The protocols for in vivo mouse experiments were reviewed and ap-
proved by the Institut de recherches cliniques de Montreal—IRCM Animal Care Committee
(ACC #2014–26), which follow the regulations and requirements of the Canadian Council on
Animal Care (CACC). Dissected neonatal kidneys from Pkd1-/- and control littermates were
homogenized and lysed in RIPA buffer, 2mM PMSF, 2μg/ml aprotinin, and cleared by centri-
fugation. Aliquots of 25 μg were loaded in each well, resolved by 10% SDS-PAGE and trans-
ferred to nitrocellulose.
Drosophila immunoblots were probed with anti d-Myc antibody (rabbit, Santa Cruz Bio-
technology, 1:2,000) or anti Thr398-phosphorylated p70 d-S6 Kinase (Cell Signaling, 1:1000),
anti-d-S6K (1199, gift of G. Thomas) and anti α tubulin (mouse, 12G10, Developmental Stud-
ies Hybridoma Bank, 1: 50,000). Mouse immunoblots were probed with anti Bicc1 (Aviva Sys-
tems Biology) polyclonal and anti-GAPDH (Sigma) antibodies. Signal was revealed via
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horseradish peroxidase-conjugated secondary antibodies (Jackson Immunoresearch) and
chemiluminescence on film (mouse) or recorded by ChemiDoc (BioRad) and analyzed (Image
Lab 5.2, Excel, Drosophila). In this study the d-Myc positive band with electrophoretic mobility
~73 kDa (consistent with the expected d-Myc molecular weight) was quantified. Values were
expressed as d-Myc/tubulin or d-S6K/tubulin intensity ratio, normalized to the average of the
wild-type and plotted as means ± standard deviation. Where appropriate, p values were deter-
mined by Student’s t test. Similar trends were obtained utilizing actin for normalization. Anti-
body controls are shown in S5 Fig.
Microscopy and immunofluorescence
Micro-dissected Malpighian tubules were photographed on a Leica MZ FLIII Fluorescence
Stereomicroscope with Leica MZ series 10X/21B Widefield Adjustable eyepieces equipped
with a Canon DS126201 EOS 5D MARK II, using visible light. Canon raw files were converted
into TIF format (Adobe Lightroom 3.2). Images were merged and processed with Adobe Pho-
toshop CS5. Immunofluorescence: dissected Malpighian tubules were fixed (20 min. in 4%
paraformaldehyde 1X PBS 0.1% Tween-20), washed in PBT, incubated with primary antibody
(anti-BicC [24] 1:1000, anti-d-Myc monoclonal 1:20, gift of Dr. Bruce Edgar) followed by
Alexa Fluor 488 or 546 conjugated secondary antibodies (Molecular Probes) and DAPI,
mounted (ProLong Gold, Molecular Probes), and imaged (Zeiss LSM710 confocal micro-
scope). Acquired images were exported as TIF files (ZEN 2012), and processed with Adobe
Photoshop CS5. 5μm thick section of paraffin-embedded, formaldehyde-fixed kidneys from
adult mice were de-paraffinized, treated with NaBH4 for 30 min, washed with TBS, 1% SDS (5
min) and washed as described above prior to blocking (mouse IgG) and probing with 1:30
anti-Bicc1 polyclonal (Aviva Systems Biology), or blocking buffer (control), followed by Alexa-
Fluor 546-conjugated secondary antibody and DAPI. Sections were mounted in ProLong
Gold. Antibody controls are shown in S5 Fig.
Immunoprecipitation and RNA assays
250 μl of packed, microdissected wild-type Malphighian tubules were lysed in ice-cold buffer
(25 mM Hepes pH 6.8, 50 mM KCl, 1 mM MgCl2, 1 mM DTT, 125 mM sucrose, 100 U/ml
RNasin (Promega) and cleared by centrifugation (10,000 g, 10 min, 4˚C). The supernatant was
brought to 0.2% Triton-X100, pre-cleared with protein A Sepharose, and incubated (2.5 hours,
4˚C) with 25 μl of protein A Sepharose Fast Flow (GE Healthcare) pre-conjugated to either
Bic-C anti-serum or non-immune control serum. The beads were washed in binding buffer,
with 0, 250, 500, 600, mM NaCl and rinsed in 250 mM NaCl containing buffer, treated with
proteinase K, extracted with phenol-chloroform and precipitated with ethanol. For the control
RNA immunoprecipitation 150 Malpighian tubules from each genotype were lysed and pro-
cessed as above. Extracts were divided equally and incubated with either non-immune or anti-
BicC immune conjugates. RNA from the immunopurified RNPs was extracted with GENEzol
(Geneaid) following recommended procedures. Recovered RNA was reverse transcribed with
Superscript II and random primers (both Invitrogen) following the manufacturer’s recom-
mendations. RT-PCR was performed with 1/10 of the reactions and the following gene specific
primers: d-Myc (Forward, F: 5’CGATCGCAGACGACAGATAA3’, Reverse, R: 5’GGGCGGT
ATTAAATGGACCT3’), tubulin 84B (F: 5’TTACGTTTGTCAAGCCTCATAGC3’, R: 5’CTG
AAGAAGGTGTTGAACGAGTC3’), BicC (F: 5’AATAGCTTTCCCGCACAACACAGC 3’, R:
5’ AAGGCAACTACGACCTATTGGCAC 3’), d-S6K (F: 5’ CAGTCAAGCATCCCTTCATA
GT 3’, R: 5’ CGGTAGATGATGCCCAGTTT 3’), d-TOR (F: 5’ AGCTCTTTCGCTGTGCCA
AT 3’, R: 5’ TCCAGTACGTTGTGGCTCGC 3’).
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Supporting information
S1 Fig. Wild type and BicCΔ/+ heterozygote flies have similar survival. Survival assays of pop-
ulations of wild-type (wt) and BicC heterozygotes for the BicC deletion (Δ/+, n = 200, with stan-
dard deviations) showing that BicC hemizygotes and wild-type flies displayed similar survival.
(TIF)
S2 Fig. Flies were fed on high salt vials containing green food dye for 30 hours, frozen and
mounted on modeling clay for photography. For image clarity legs were clipped.
(TIF)
S3 Fig. (A) Representative d-Myc and tubulin immunoblots of extracts from five Malpighian
tubules dissected from flies of the following genotypes: d-myc RNAi driven in BicCYC33/YC33
homozygotes (BicCYC33; Gal4>mycRNAi); BicCYC33/YC33 homozygotes (BicCYC33, sibling to the
previous flies); wild-type (wt); heterozygotes for BicCYC33 and the c42 Gal4 driver. The TRiP
line used in these assays was JF01761. (B) Corresponding graph summarizing quantitative
immunoblots of means ± standard deviations of d-Myc/tubulin ratios from independent bio-
logical replicas per each genotype (n, indicated). Values were normalized to the wild-type aver-
age; p values (Student’s t test) are shown for the BicC mutants and rescued flies. For the latter,
significance was computed compared to wild type (top) and BicC mutant (below). Reducing d-
myc expression in BicCYC33/YC33 mutants decreased the d-Myc protein.
(TIF)
S4 Fig. BicC alleles BicCYC33 and BicCIIF34 produce truncated proteins. BicC immunoblots
of extracts from dissected ovarian stages 1–9 (20 μg/lane) of the following genotypes: OreR
(wild type, wt, lane 1); BicCΔ/YC33 (lane 2); BicCΔ/IIF34 (lane 3); w EGFPnos (E, Forrest et al.
2004, lane 4); w EGFPnos; BicCΔ/YC33 (E; BicCΔ/YC33; lane 5); w EGFPnos; BicCΔ/IIF34 (E; BicCΔ/
IIF34; lane 6) show that both BicCΔ/YC33 and BicCΔ/IIF34 flies produced truncated BicC proteins
(asterisks), compared to the full-length BicC protein found in wild type and the w EGFPnos
ovaries (lanes 1 and 4, respectively). The smudge at ~ 100 kDa in lane 6 was due to spill over
from the sample in the next well.
(TIF)
S5 Fig. Antibody controls. (A) Whole d-Myc immunoblot for the gel in Fig 7F. d-Myc is indi-
cated with an asterisk. The molecular size marker is shown (colorimetric image, left) and cor-
responding sizes are specified. Red indicates areas of over-exposure. (B) Immunoblot of
Malpighian tubule extracts from mycP0/dm1, OreR (wt), Gal4>TRiP.JF01761,Gal4>TRiP.
JF01762. (A, B): rabbit polyclonal anti-d-Myc. (C) Confocal section of Myc immunostaining of
OreR (wt) with anti-Myc monoclonal B10. (D) Confocal section of Myc immunostaining of
mycP0/dm1 Malpighian tubules with anti-d-Myc monoclonal B10; mycP0/dm1 was obtained by
crossing strong hypomorphic mutants [44,65]. (E) Epifluorescence microscopy of a 5 μm kid-
ney section from C57BL/6 mice shows Bicc1 accumulation in the cells lining the renal tubule
and DNA (DAPI, blue). This is the same panel shown in (Fig 3E–3G). (F) A 5 μm kidney sec-
tion from C57BL/6 mice was processed in parallel and identical conditions to (E), except for
the addition of the primary anti-Bicc1 antibody. All image pairs were captured in identical
conditions and the corresponding samples processed in parallel. (G) Epifluorescence micros-
copy of a mosaic Malpighian tubule displaying a single cell expressing a long dsRNA targeting
BicC (Valium 20 P{TRiP.HMS01407}) and marked by GFP co-expression, surrounded by
neighbouring wild-type cells. The clone boundaries are indicated. (C-G): DNA (DAPI), blue.
Scale bars indicated.
(TIF)
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S1 Text. Supporting methods describing the d-myc alleles in S5 Fig and procedures for
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